Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Mark Shahin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Finished
-
Sidney Kimmel Cancer Center LAPS Institutional Collaboration
Johnson, J. (PI), Mitchell, E. E. P. (CoPI), Werner-Wasik, M. (CoPI), Shahin, M. (CoPI), Edelson, M. I. (CoPI), Schilder, R. (CoPI) & Cohen, S. J. (CoPI)
3/5/19 → 2/28/26
Project: Research project
-
Comparative outcomes of nab-paclitaxel and paclitaxel in platinum-resistant ovarian cancer (COMPASS)
Shahin, M. S., Mathur, R., Parthan, A., Yerram, P., Kesner-Hays, A., Myers, R., Tudor, I. C., Dobler, D., Jubb, A. M. & Coleman, R. L., Jan 2026, In: Gynecologic Oncology. 204, p. 202-209 8 p.Research output: Contribution to journal › Article › peer-review
Open Access -
A Plain Language Summary of “Dostarlimab for primary advanced or recurrent endometrial cancer”
Mirza, M. R., Chase, D. M., Slomovitz, B. M., Christensen, R. D. P., Novák, Z., Black, D., Gilbert, L., Sharma, S., Valabrega, G., Landrum, L. M., Hanker, L. C., Stuckey, A., Boere, I., Gold, M. A., Auranen, A., Pothuri, B., Cibula, D., McCourt, C., Raspagliesi, F. & Shahin, M. S. & 11 others, , 2025, In: Future Oncology. 21, 2, p. 151-168 18 p.Research output: Contribution to journal › Article › peer-review
-
A plain language summary publication of patients’ survival with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel
Powell, M. A., Bjørge, L., Willmott, L., Novák, Z., Black, D., Gilbert, L., Sharma, S., Valabrega, G., Landrum, L. M., Gropp-Meier, M., Stuckey, A., Boere, I., Gold, M. A., Segev, Y., Gill, S. E., Gennigens, C., Sebastianelli, A., Shahin, M. S., Pothuri, B. & Monk, B. J. & 11 others, , Jan 1 2025, In: Therapeutic Advances in Medical Oncology. 17, 17588359251342241.Research output: Contribution to journal › Review article › peer-review
Open Access -
Efficacy and safety of dostarlimab in combination with chemotherapy in patients with dMMR/MSI-H primary advanced or recurrent endometrial cancer in a phase 3, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY)
Powell, M. A., Cibula, D., O'Malley, D. M., Boere, I., Shahin, M. S., Savarese, A., Chase, D. M., Gilbert, L., Black, D., Herrstedt, J., Sharma, S., Kommoss, S., Gold, M. A., Thijs, A. M., Ring, K., Bolling, M. F., Buscema, J., Gill, S. E., Nowicki, P. & Nevadunsky, N. & 10 others, , Jan 2025, In: Gynecologic Oncology. 192, p. 40-49 10 p.Research output: Contribution to journal › Article › peer-review
Open Access13 Link opens in a new tab Scopus citations -
Evaluation of efficacy and fertility after nonradical surgical therapy (extra fascial hysterectomy or cone biopsy, with pelvic lymphadenectomy) for stage IA1, IA2, and IB1 cervical cancer (GOG-0278)
Covens, A., Huang, H. Q., Monk, B. J., Kim, Y. B., Kim, M. H., DiSilvestro, P., Vicus, D., Holman, L. L., Fleury, A., Pearson, J. M., Thawani, N., Shahin, M. S., Lea, J. S., Robertson, S. E., Warshal, D., Backes, F., Feltmate, C., Dewdney, S., Leitao, M. M. & Wilkinson-Ryan, I. & 2 others, , Apr 2025, In: Gynecologic Oncology. 195, p. 59-65 7 p.Research output: Contribution to journal › Article › peer-review
8 Link opens in a new tab Scopus citations